Riskpilot← Back to searchSign inGet full accessVaccinationsguiden AB
ABActiveOrg 5564989670Lindengatan 51Other human health activities n.e.c. · NACE 8699Est. 19942 employees
Revenue 2025
SEK 1,4M
+3% vs 2024
EBITDA margin
-7.2%
+27% vs 2024
Equity ratio
95.0%
Financial strength
Net profit 2025
SEK 757K
+39% vs 2024
| Revenue | SEK 1,4M | +3% |
| EBITDA | SEK -101K | +27% |
| Net profit | SEK 757K | +39% |
| Total assets | SEK 15,3M | +1% |
| Equity | SEK 14,6M | +3% |
| Employees | 2 | — |
Legal name
Vaccinationsguiden AB
Org number
5564989670
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
8 december 1994
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva vaccinations- och profylaxrådgivning i form av publikation och datamedia till medicinpersonal samt epidemiologisk kartläggning, äga och förvalta aktier och andra värdepapper, samt därmed förenlig verksamhet.
Address
Lindengatan 51
Phone
+4613100443
Email
per.benno@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 998 | 1 133 | 1 672 | 1 354 | 1 393 |
| Staff expenses | — | −763 | −841 | −824 | −933 |
| EBITDA | −243 | −295 | −153 | −138 | −101 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | −243 | −295 | −153 | −138 | −101 |
| Net financials | 319 | 674 | 300 | 581 | 563 |
| Profit before tax | 303 | 878 | 247 | 544 | 812 |
| Tax | −2 | −50 | −0 | — | −55 |
| Net profit | 301 | 829 | 247 | 544 | 757 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 15 261 | 15 287 | 15 215 | 15 187 | 15 329 |
| Equity | 13 578 | 14 080 | 13 976 | 14 170 | 14 561 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 633 | 657 | 789 | 667 | 768 |
| Total debt | 633 | 657 | 789 | 667 | 768 |
EBITDA margin
-7.2%
This company
15.8%
Market median
-146% vs market
20212025
Equity ratio
95.0%
This company
38.2%
Market median
+149% vs market
20212025
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
20212025
Net profit margin
54.3%
This company
8.1%
Market median
+570% vs market
20212025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20212025
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BM Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Deputy Board Member | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vaccinationsguiden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Magnus Hallberg | Chief Auditor | 0 companies |
| Per Lennart Benno | Board of Directors | 0 companies |
| Peter Michael Benno | Deputy Board Member | 0 companies |